NeuralPort Partners with Rohto Pharmaceutical in Seed Fundraising Success
Category: Funding
NeuralPort Secures Seed Funding from Rohto Pharmaceutical to Advance ZONE-Z, a Scientific Approach to Recreating the "Zone" State.
We are deeply inspired by Rohto Pharmaceutical's DNA of "NEVER SAY NEVER" and "Doing what others won’t." With this philosophy, we aim to develop and deliver products that enhance humanity on a global scale. As we approach Expo 2025 in Osaka, we will intensify our research efforts. Message from Kunio Yamada,Chairman of Rohto Pharmaceutical Co., Ltd.: "We fully support and encourage the challenge taken on by these two young sisters! Keep running toward the new possibilities of collaboration between humans and machines!" NeuralPort was founded by two sisters—an older sister currently pursuing a doctorate at Osaka University Graduate School and a younger sister who is a former boxer. Based in Ashiya City, Hyogo Prefecture, all executives, researchers, and developers operate fully remotely, conducting meetings in virtual reality (VR). Vision:"Creating the ordinary of the future"Mission:"Evolving humanity through technology"Headquarters:428 Kominatocho C4, Ashiya City, Hyogo Prefecture, 6590065 Established: September 15, 2020 URL:https://neuralport.studio.site/ Back to News List About NeuralPort Inc. NeuralPort Inc. is committed to achieving human potential through cuttingedge technology. The company specializes in the development of innovative tools such as the ZEN EYE Pro, a stresscheck system using gazetracking, and ZONEZ, a training platform that replicates the "zone" state. Headquarters: 18 Iwaencho, Ashiya City, Hyogo Prefecture, Japan Established: September 2020 Website: https://neuralport.io
すべてのニュース